<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="156305">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01797692</url>
  </required_header>
  <id_info>
    <org_study_id>PROGE</org_study_id>
    <secondary_id>2011-A01256-35</secondary_id>
    <nct_id>NCT01797692</nct_id>
  </id_info>
  <brief_title>Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study</brief_title>
  <acronym>PROGE</acronym>
  <official_title>Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Francois Baclesse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Francois Baclesse</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicenter pilot study, proposed for cases and controls 3 departments in France.

      Cases are cured patients who have had prostate cancer for at least 10 years. Cookies are
      healthy subjects selected by lottery on voter list.

      Volunteer subjects (cases and controls) are offered a consultation and assessment with an
      geriatrician.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Volunteer subjects (cases and controls) are offered a consultation and assessment with an
      geriatrician.

      During this consultation, ADL, IADL and MMS questionnary will be completed. neurocognitif
      testing will be done.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>impact of treatments</measure>
    <time_frame>10 years after treatment for cancer prostate</time_frame>
    <safety_issue>No</safety_issue>
    <description>The main objective of this study is to evaluate the impact of treatments and their effects on the autonomy of patients over 75 years have been treated and cured for prostate cancer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the anxiety of patients and controls</measure>
    <time_frame>10 years after treatment for cancer prostate</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate the anxiety of patients and controls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing depression patients and controls</measure>
    <time_frame>10 years after treatments for cancer prostate</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assessing depression patients and controls</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the nutritional status of patients and controls</measure>
    <time_frame>10 years after treatments for cancer prostate</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess the nutritional status of patients and controls</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Prostate Cancer Cured</condition>
  <condition>Healthy Population Control</condition>
  <arm_group>
    <arm_group_label>geriatric assessment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>geriatric assessment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>geriatric assessment</intervention_name>
    <description>A single geriatric assessment with a geriatrician was proposed to patients and to control population.</description>
    <arm_group_label>geriatric assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for patients:

          -  Patients aged 75 years or more

          -  Patients with a personal history of prostate cancer with a diagnosis ≥ 10 years

          -  Patients who received curative treatment (surgery, radiotherapy,hormone therapy,
             brachytherapy, technical ablative) for localized prostate cancer

          -  Patients considered cured of prostate cancer (regardless of initial treatment)

          -  Patients with previously agreed to participate in a case-control study in the general
             population (study QALIPRO) as a case and volunteer to receive an assessment of
             geriatric

          -  Signature of consent

          -  Affiliation to a social security system

        Exclusion Criteria for patients:

          -  Patients under 75 years

          -  Patients with recurrent or metastatic

          -  Persons deprived of liberty or under guardianship

        Inclusion Criteria for control population:

          -  Male subjects

          -  Subjects of 75 years or more

          -  Subjects that do not have cancer or a history of cancer (except basal cell skin
             cancer)

          -  Subject has previously agreed to participate in a case-control study in the general
             population (study QALIPRO) as a voluntary witness and to benefit from a balance
             oncogeriatrics

          -  Subjects who gave their written consent to participate in the study
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>75 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Emmanuel SEVIN, MD</last_name>
    <phone>02 31 45 50 50</phone>
    <email>e.sevin@baclesse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Valérie GUIZARD, MD</last_name>
    <phone>02 31 45 50 50</phone>
    <email>av.guizard@baclesse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hopitaux universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <state>Bas-Rhin</state>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Damien HEITZ, MD</last_name>
    </contact>
    <investigator>
      <last_name>Damien HEITZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre François BACLESSE</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel SEVIN, MD</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel SEVIN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne LAROCHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heidi LAVIEC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Claude BERNARD</name>
      <address>
        <city>Albi</city>
        <zip>81000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvestre AMAURY, MD</last_name>
    </contact>
    <investigator>
      <last_name>Sylvestre AMAURY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHIC</name>
      <address>
        <city>Castres</city>
        <zip>81 000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Noelle CUFI, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marie Noëlle CUFI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Corinne COSTES, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amandine LEFORT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc ALONSO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 17, 2013</lastchanged_date>
  <firstreceived_date>February 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prostate cancer cured</keyword>
  <keyword>aged patients</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
